180 related articles for article (PubMed ID: 25844674)
1. Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry.
Conner JR; Hornick JL
Adv Anat Pathol; 2015 May; 22(3):149-67. PubMed ID: 25844674
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of unknown primary: check the liver... thanks to TTF-1.
Mishra M; Morgan V; Hamati AK; Al-Abbadi M
Tenn Med; 2012 Jan; 105(1):35-6, 40. PubMed ID: 22359993
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
[TBL] [Abstract][Full Text] [Related]
4. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
Chiesa-Vottero A
Int J Gynecol Pathol; 2020 Mar; 39(2):170-177. PubMed ID: 32045390
[TBL] [Abstract][Full Text] [Related]
5. Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach.
DeYoung BR; Wick MR
Semin Diagn Pathol; 2000 Aug; 17(3):184-93. PubMed ID: 10968704
[TBL] [Abstract][Full Text] [Related]
6. SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary.
Dabir PD; Svanholm H; Christiansen JJ
APMIS; 2018 Jun; 126(6):494-500. PubMed ID: 29924451
[TBL] [Abstract][Full Text] [Related]
7. Identification of carcinoma origin by thyroid transcription factor-1 immunostaining of fine needle aspirates of metastases.
Strojan Flezar M; Srebotnik Kirbis I
Cytopathology; 2009 Jun; 20(3):176-82. PubMed ID: 18373697
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
Alberti C
G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
[TBL] [Abstract][Full Text] [Related]
9. Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site.
Qaseem A; Usman N; Jayaraj JS; Janapala RN; Kashif T
Cureus; 2019 Sep; 11(9):e5552. PubMed ID: 31695975
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary.
Nguyen TT; Kreisel FH; Frater JL; Bartlett NL
J Clin Oncol; 2013 Nov; 31(33):e443-5. PubMed ID: 23775969
[No Abstract] [Full Text] [Related]
11. Practical Applications in Immunohistochemistry: Carcinomas of Unknown Primary Site.
Kandalaft PL; Gown AM
Arch Pathol Lab Med; 2016 Jun; 140(6):508-23. PubMed ID: 26457625
[TBL] [Abstract][Full Text] [Related]
12. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study.
Dragomir A; de Wit M; Johansson C; Uhlen M; Pontén F
Am J Clin Pathol; 2014 May; 141(5):630-8. PubMed ID: 24713733
[TBL] [Abstract][Full Text] [Related]
13. [CUP syndrome: are there advances?].
Moll R
Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
[TBL] [Abstract][Full Text] [Related]
14. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours.
Rabban JT; Zaloudek CJ
Histopathology; 2013 Jan; 62(1):71-88. PubMed ID: 23240671
[TBL] [Abstract][Full Text] [Related]
15. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry, carcinomas of unknown primary, and incidence rates.
Stelow EB; Yaziji H
Semin Diagn Pathol; 2018 Mar; 35(2):143-152. PubMed ID: 29224972
[TBL] [Abstract][Full Text] [Related]
17. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
Su YC; Hsu YC; Chai CY
Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
Onofre AS; Pomjanski N; Buckstegge B; Böcking A
Cancer; 2007 Aug; 111(4):259-68. PubMed ID: 17567831
[TBL] [Abstract][Full Text] [Related]
19. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
Chia SY; Thike AA; Cheok PY; Tan PH
Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical panel of antibodies in the diagnosis of brain metastases of the unknown primary.
Drlicek M; Bodenteich A; Urbanits S; Grisold W
Pathol Res Pract; 2004; 200(10):727-34. PubMed ID: 15648611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]